Literature DB >> 19121252

Reasons to exercise caution when considering a screening program for type 2 diabetes mellitus.

Frank H Lawler1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19121252      PMCID： PMC2664560          DOI： 10.1016/S0025-6196(11)60805-7

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  9 in total

1.  Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. Evidence-Based Medicine Working Group.

Authors:  A Barratt; L Irwig; P Glasziou; R G Cumming; A Raffle; N Hicks; J A Gray; G H Guyatt
Journal:  JAMA       Date:  1999-06-02       Impact factor: 56.272

2.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors:  Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

Review 3.  Back to Wilson and Jungner: 10 good reasons to screen for type 2 diabetes mellitus.

Authors:  Ann M Sheehy; Douglas B Coursin; Robert A Gabbay
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

4.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

5.  10-year follow-up of intensive glucose control in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; David R Matthews; H Andrew W Neil
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

6.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

7.  Effects of intensive glucose lowering in type 2 diabetes.

Authors:  Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal:  N Engl J Med       Date:  2008-06-06       Impact factor: 91.245

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-06-03       Impact factor: 25.391
  9 in total
  2 in total

1.  Revisiting screening for type 2 diabetes mellitus: to screen or not to screen, that is the question.

Authors:  Saleh A Aldasouqi; Ved V Gossain
Journal:  Mayo Clin Proc       Date:  2009-04       Impact factor: 7.616

2.  Development and validation of a patient self-assessment score for diabetes risk.

Authors:  Heejung Bang; Alison M Edwards; Andrew S Bomback; Christie M Ballantyne; David Brillon; Mark A Callahan; Steven M Teutsch; Alvin I Mushlin; Lisa M Kern
Journal:  Ann Intern Med       Date:  2009-12-01       Impact factor: 25.391
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.